Tommy Roe, DPM
Foot & Ankle Surgery · Albuquerque, NMNPI 1720077050
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,864 of the $3,283 with a category attached, or 87.2%. 11 manufacturers reported payments, led by Stryker at 37.4% of the total.
Across 93 payments — averaging $35.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Smith+Nephew$714
- Kerecis Limited$558
- Treace Medical Concepts, Inc.$256
- Rikco International, LLC$173
- Organogenesis Inc.$154
- plus $201 from 5 others
What the payments were for
- Speaking & faculty fees$1274%
- Travel & lodging$1184%
- Food & beverage$2,86487%
- Education$1745%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 38 | $1,227 |
| Smith+Nephew | 32 | $714 |
| Kerecis Limited | 5 | $558 |
| Treace Medical Concepts, Inc. | 7 | $256 |
| Rikco International, LLC | 2 | $173 |
| Organogenesis Inc. | 2 | $154 |
| DJO, LLC | 3 | $96 |
| Johnson & Johnson | 1 | $52 |
| Medtronic | 1 | $18 |
| Bioventus LLC | 1 | $18 |
| Gemini Mountain Medical, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$1,218
- Kerecis Omega3 SurgiClose$741
- Kerecis Omega3 GraftGuide$333
- PROPHECY$175
- Actishield$149
- DR. COMFORT Diabetic Shoes and Inserts$145
- ORTHOLOC 3DI$135
- LAPIPLASTY SYSTEM 1$129
- Apligraf$127
- Dermagraft$127
- Puraply/Affinity/NuTech$127
- Santyl$112
- REGRANEX$112
- Oasis$112
How this compares
$3,283 in reported general payments places this provider in the 55th percentile of 69 foot & ankle surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 39 | $374 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $264 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $190 |
| Doxycycline Hyclate | 29 | $139 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Albuquerque
- Mark MargiottaAlbuquerque$12K
- Jason DunnAlbuquerque$10K
- Alexander JenksAlbuquerque$9K
- Marshall MonsonAlbuquerque$9K
- Chad SmithAlbuquerque$9K
- Mark TennyAlbuquerque$8K
- Eve HuiAlbuquerque$6K
- Haywan ChiuAlbuquerque$5K
- Steven WregeAlbuquerque$4K
- Shama PervaizAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.